Eye health is important for everyone, but especially for those with diabetes. People with diabetes have high blood glucose levels that, over time, can damage the eyes. Diabetic eye disease covers a group of eye conditions including diabetic macular edema, cataract and glaucoma. Each has the potential to cause sever vision loss or blindness if left untreated. Controlling diabetes with medication, physical activity and a healthy diet can help slow the progress of these eye conditions.
Diabetic retinopathy often goes unnoticed until vision loss occurs, so people with diabetes should make sure to have an eye exam at least once per year for early detection and treatment. And with the right tools, eye screening for diabetic retinopathy is made both simple and affordable for primary care.
If you’re a health-care provider looking to improve management of patients with diabetes, there are tools that can help. For example, The RetinaVue Network is designed to help providers easily perform retinal exams in a primary care setting with only four simple steps.
Find the tools you need to offer the best and most affordable care for your patients. Browse our selection to add simple, affordable and effective equipment to your practice.
Diabetic retinopathy is the leading cause of blindness in working-age adults, affecting millions of Americans today. What’s even more worrisome is that primary-care practices can prevent vision loss caused by diabetic retinopathy, but many don’t have the equipment to run assessment tests. It’s high time the medical industry becomes aware there’s now new technology that can save patients’ vision, and it’s incredibly easy and cost-effective to use.
The Welch Allyn RetinaVue Network is an affordable and effective diabetic retinopathy screening tool that can double patient-compliance rates in just 12 months. It involves an incredibly simple four-step process, which is outlined below.
Acquire: After entering required patient information, use the RetinaVue RV 100 Imager to acquire images of each eye. You’ll know the image is successful when the green checkmark appears on the camera. Remember to save the good-quality images.
Transfer: Place the RV 100 Imager in the docking station and click “Submit Exam” to transfer images.
Analyze: After transferring images, a board-certified retinal specialist will evaluate the exam. The specialist will identify, classify and document all levels of diabetic retinopathy.
Report: A diagnostic report provided by the retinal specialist will be returned that same day. This report includes the patient information, images, a diagnostic report and referral/screening plan.
Patients shouldn’t have to suffer from vision loss caused by diabetic retinopathy, a highly treatable condition. Bring the Welch Allyn RetinaVue Network into your primary-care practice to improve patient care and earn in more revenue. You can visit Medical Device Depot today to learn more.
In working-age adults, diabetic retinopathy (a condition that affects those with diabetes) is the leading cause of vision impairment. Over time, diabetes can damage blood vessels in the retina, eventually causing the vessels to leak blood and other fluids. This results in cloudy and blurred vision, which can be treated but not cured. For the best possible outcome, diabetic patients should come in for a yearly diabetic retinopathy screening, which can detect the condition in its early stages and limit the amount of vision loss that patient will experience. This is where the Welch Allyn RetinaVue 100 Imager can significantly help your practice.
The RetinaVue 100 Imager uses a simple and affordable four-step process to accurately screen for diabetic retinopathy. Results are provided the same day, usually within just 90 minutes. Because this screening device can detect the condition early, it can save patients large sums of money in treatment costs. The national average reimbursement to use this service is $75 per exam, helping hospitals save money, too.
Improve patient care in your practice by offering diabetic retinopathy screening. You can find the RetinaVue 100 Imager, and more important equipment, for an affordable cost at Medical Device Depot today.
At Medical Device Depot, we pride ourselves on offering high-quality and affordable medical equipment. Our collection includes tools from the best medical device manufacturing companies such as visionaries like Welch Allyn. For years, Welch Allyn has helped health care providers deliver excellent patient care. Recently, the company made a breakthrough in the health care industry with its RetinaVue 100 Imager. Let’s take a closer look at this superior diabetic retinopathy screening device and more equipment from Welch Allyn.
The RetinaVue 100 Imager
Millions of people living with diabetes today aren’t screened for diabetic retinopathy, a disease that can cause blindess if not treated early. This will change thanks to the RetinaVue 100 Imager’s affordable cost. This device costs two-thirds less than alternative screening solutions, making it the practical option for both primary care providers and patients. When you buy The RetinaVue 100 Imager through Medical Device Depot, the national average reimbursement is $75 per exam. You can also expect double HEDIS compliance rates for diabetic retinal assessment in 12 months.
More high-quality equipment
Along with innovative eye screening solutions, Welch Allyn offers a wide range of routine physical tools, such as otoscopes and stethoscopes. Every medical device is designed to provide the highest level of care at a reasonable cost.
Stock your medical practice with the brands you can trust. Find a wide selection of Welch Allyn medical supplies at Medical Device Depot today.
More than one million people will develop in their lifetime a form a diabetic retinopathy, an eye disorder that affects those with diabetes and causes vision impairment. Diabetic retinopathy is a leading cause of blindness in working-age adults and it unfortunately often goes undetected until it is too late and the damage is already done. This doesn’t have to be the case, however. If detected early, you can prevent around 95 percent of vision loss in patients diagnosed with this eye disease. You just need the right equipment at your practice to provide effective and affordable diabetic retinopathy screening.
The Welch Allyn RetinaVue Network allows you to easily incorporate retinal exams during primary care, doubling patient compliance rates and increasing revenue for your practice. It’s an affordable solution for patients, as many common health-care plans offer reimbursement for screenings. The national average reimbursement for using the service is 75 dollars per exam, which means the RetinaVue Network is affordable for your clinic as well.
The RetinaVue Network uses a simple, four-step process to screen patients and provide accurate results. First, an image is acquired using an automated non-mydriatic camera. The image is then sent to a board-certified retinal specialist through a secure network. The image is evaluated by this specialist, and that same day, the a diagnostic report and management plan is sent back to the provider. The results are typically returned in just 90 minutes.
Invest in medical equipment that benefits both your patients and the practice. The Welch Allyn RetinaVue 100 Imager can be purchased or leased through Medical Device Depot today.